SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-18-004055
Filing Date
2018-01-26
Accepted
2018-01-26 16:42:54
Documents
2
Group Members
RIDGEBACK CAPITAL INVESTMENTS LTD.RIDGEBACK CAPITAL MANAGEMENT LP

Document Format Files

Seq Description Document Type Size
1 SC 13G tv484050_sc13g.htm SC 13G 81384
2 JOINT FILING AGREEMENT tv484050_ex99-1.htm EX-99.1 6398
  Complete submission text file 0001144204-18-004055.txt   89415
Mailing Address 500 SOUTH POINTE DRIVE SUITE 220 MIAMI BEACH FL 33139
Business Address 500 SOUTH POINTE DRIVE SUITE 220 MIAMI BEACH FL 33139 212-808-7729
Ridgeback Capital Investments L.P. (Filed by) CIK: 0001423994 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Subject) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87705 | Film No.: 18552452
SIC: 2834 Pharmaceutical Preparations